Generic and brand name antiretroviral drugs are becoming increasingly available in developing countries. We analyzed 6 antiretroviral medications from 4 international sources for drug content. The active ingredient in tested drug products was within 15 % of the labeled amount (range, 12 % to +15%) for drugs that were properly stored. Combination antiretroviral therapy has dramatically reduced morbidity and mortality secondary to HIV infection [1]. In the developing world, at least 6 million of the 42 million HIV-infected patients are in urgent need of antiretroviral medica-tions, yet because of the high costs,!300,000 are receiving treatment. However, generic antiretroviral medications, along with discounted brand name products, are quickly...
As the world enters the fourth decade of the HIV/AIDS epidemic a number of new drugs have been devel...
International audienceThe pediatric antiretroviral (ARV) market is poorly described in the literatur...
Affordability is a key concern of international donors who finance antiretroviral drugs to treat AID...
Generic and brand name antiretroviral drugs are becoming increasingly available in developing countr...
Significant quantities of antiretroviral drugs (ARVs) to treat HIV/AIDS have been procured for Sub-S...
BACKGROUND: Significant quantities of antiretroviral drugs (ARVs) to treat HIV/AIDS have been procur...
The introduction of generic antiretroviral medications in developing countries has resulted in signi...
As of 2011, over 34 million people lived with HIV/AIDS, and about 95 percent of this population live...
Highly active antiretroviral therapy has significantly modified the natural history of HIV infectio...
Access to treatment is a key part of national strategies to combat HIV/AIDS. Antiretrovirals can inc...
BACKGROUND Indian manufacturers of generic antiretroviral (ARV) medicines facilitated the rapid scal...
Introduction: Antiretrovirals are available at low prices in sub-Saharan Africa, but these prices ma...
Background: Indian manufacturers of generic antiretroviral (ARV) medicines facilitated the rapid sca...
Since the discovery of HIV as the causative agent of AIDS in 1983/1984, remarkable progress has been...
Abstract Background The price of antiretroviral drugs (ARVs) in low income countries declined steadi...
As the world enters the fourth decade of the HIV/AIDS epidemic a number of new drugs have been devel...
International audienceThe pediatric antiretroviral (ARV) market is poorly described in the literatur...
Affordability is a key concern of international donors who finance antiretroviral drugs to treat AID...
Generic and brand name antiretroviral drugs are becoming increasingly available in developing countr...
Significant quantities of antiretroviral drugs (ARVs) to treat HIV/AIDS have been procured for Sub-S...
BACKGROUND: Significant quantities of antiretroviral drugs (ARVs) to treat HIV/AIDS have been procur...
The introduction of generic antiretroviral medications in developing countries has resulted in signi...
As of 2011, over 34 million people lived with HIV/AIDS, and about 95 percent of this population live...
Highly active antiretroviral therapy has significantly modified the natural history of HIV infectio...
Access to treatment is a key part of national strategies to combat HIV/AIDS. Antiretrovirals can inc...
BACKGROUND Indian manufacturers of generic antiretroviral (ARV) medicines facilitated the rapid scal...
Introduction: Antiretrovirals are available at low prices in sub-Saharan Africa, but these prices ma...
Background: Indian manufacturers of generic antiretroviral (ARV) medicines facilitated the rapid sca...
Since the discovery of HIV as the causative agent of AIDS in 1983/1984, remarkable progress has been...
Abstract Background The price of antiretroviral drugs (ARVs) in low income countries declined steadi...
As the world enters the fourth decade of the HIV/AIDS epidemic a number of new drugs have been devel...
International audienceThe pediatric antiretroviral (ARV) market is poorly described in the literatur...
Affordability is a key concern of international donors who finance antiretroviral drugs to treat AID...